How to achieve both cost and quality goals in plasmid manufacturing

Cell & Gene Therapy Insights 2023; 9(8), 1087;

10.18609/cgti.2023.142

Published: 22 September 2023
FastFacts
Silvia Orsini


Watch the video or view the poster for insights into: 

  • Evolving regulatory landscape and guidance on use of GMP material      
  • How to mitigate risk through use of full GMP quality plasmid throughout the product lifecycle
  • Adopting a phase-appropriate approach with plasmid DNA

View pdf






We hope you enjoyed this FastFacts video. You can also view the poster summary here

Authorship & conflict of interest

Contributions: The named author takes responsibility for the integrity of the work as a whole, and has given her approval for this version to be published.

Acknowledgements: None.

Disclosure and potential conflicts of interest: The author is an employee of Thermo Fisher Scientific.

Funding declaration: The author received no financial support for the research, authorship and/or publication of this article.

Article & copyright information

Copyright: Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Attribution: Copyright © 2023 Thermo Fisher Scientific. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.

Article source: From a FastFacts video recorded on Aug 14, 2023; Publication date: Sep 20, 2023.


This article is part of the Scale-up/-out of cell & gene therapy manufacturing spotlight